{"id":"W2765485679","doi":"10.1158/1078-0432.ccr-17-2260","title":"A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in <i>PIK3CA</i> -Mutated Breast and Gynecologic Cancers","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":146,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"National Institute for Health and Care Research; Cancer Research UK; Astex Pharmaceuticals; Imperial Experimental Cancer Medicine Centre; AstraZeneca","keywords":"Medicine; Tolerability; Adverse effect; Common Terminology Criteria for Adverse Events; Pharmacodynamics; Pharmacokinetics; Dosing; Rash; Internal medicine; Nausea; Breast cancer; Oncology; Regimen; Phases of clinical research; Pharmacology; Toxicity; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007679082,0.000141679,0.0003679788,0.00008550356,0.0002575001,0.0001610084,0.0007627581,0.0001412523,0.000008940492],"category_scores_gemma":[0.003157726,0.0001144432,0.00003609836,0.0002057252,0.0004878295,0.00002256611,0.001080803,0.0003555181,4.183825e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002374151,"about_ca_system_score_gemma":0.001137158,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003282016,"about_ca_topic_score_gemma":0.01546512,"domain_scores_codex":[0.997125,0.0007295848,0.00060456,0.0007229178,0.0004050879,0.0004128308],"domain_scores_gemma":[0.9982373,0.0003008718,0.0002375225,0.0006496798,0.0004488337,0.0001258428],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01452103,0.005391679,0.3827672,0.0002169535,0.0002191484,0.00002194981,0.001331449,0.0003263192,0.4547749,0.000007745968,0.004178276,0.1362434],"study_design_scores_gemma":[0.1342174,0.01562406,0.6892203,0.001705521,0.0001669016,0.00001507107,0.003075662,0.006278567,0.1468475,0.0009228101,0.0009440292,0.0009821702],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946463,0.000744785,0.00000632789,0.0009733997,0.000237112,0.003256445,0.00008132395,0.000002452045,0.00005181994],"genre_scores_gemma":[0.99831,0.0001692408,0.00005989297,0.0001540571,0.0001786807,0.001029039,0.000007330692,0.00002251341,0.00006925444],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3079274,"threshold_uncertainty_score":0.8629901,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2654129356727883,"score_gpt":0.5986973071580772,"score_spread":0.3332843714852889,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}